128 related articles for article (PubMed ID: 17294127)
41. Functional iron deficiency and diastolic function in heart failure with preserved ejection fraction.
Kasner M; Aleksandrov AS; Westermann D; Lassner D; Gross M; von Haehling S; Anker SD; Schultheiss HP; Tschöpe C
Int J Cardiol; 2013 Oct; 168(5):4652-7. PubMed ID: 23968714
[TBL] [Abstract][Full Text] [Related]
42. Functional improvement in heart failure patients treated with beta-blockers is associated with a decline of cytokine levels.
Mayer B; Holmer SR; Hengstenberg C; Lieb W; Pfeifer M; Schunkert H
Int J Cardiol; 2005 Aug; 103(2):182-6. PubMed ID: 16080978
[TBL] [Abstract][Full Text] [Related]
43. Lipotab, a polyherbal formulation, attenuates isoprenaline-induced left ventricular remodeling and heart failure in rats.
Sharma A; Mediratta PK; Sharma KK; Fahim M
Hum Exp Toxicol; 2011 Aug; 30(8):1000-8. PubMed ID: 20889581
[TBL] [Abstract][Full Text] [Related]
44. Baicalein attenuates angiotensin II-induced cardiac remodeling via inhibition of AKT/mTOR, ERK1/2, NF-κB, and calcineurin signaling pathways in mice.
Wang AW; Song L; Miao J; Wang HX; Tian C; Jiang X; Han QY; Yu L; Liu Y; Du J; Xia YL; Li HH
Am J Hypertens; 2015 Apr; 28(4):518-26. PubMed ID: 25362112
[TBL] [Abstract][Full Text] [Related]
45. Impairment of cardiac function and remodeling induced by myocardial infarction in rats are attenuated by the nonpeptide angiotensin-(1-7) analog AVE 0991.
Zeng WT; Chen WY; Leng XY; Tang LL; Sun XT; Li CL; Dai G
Cardiovasc Ther; 2012 Jun; 30(3):152-61. PubMed ID: 21167013
[TBL] [Abstract][Full Text] [Related]
46. A Phase II, randomized, double-blind, multicenter, based on standard therapy, placebo-controlled study of the efficacy and safety of recombinant human neuregulin-1 in patients with chronic heart failure.
Gao R; Zhang J; Cheng L; Wu X; Dong W; Yang X; Li T; Liu X; Xu Y; Li X; Zhou M
J Am Coll Cardiol; 2010 May; 55(18):1907-14. PubMed ID: 20430261
[TBL] [Abstract][Full Text] [Related]
47. Ranolazine, a partial fatty acid oxidation (pFOX) inhibitor, improves left ventricular function in dogs with chronic heart failure.
Sabbah HN; Chandler MP; Mishima T; Suzuki G; Chaudhry P; Nass O; Biesiadecki BJ; Blackburn B; Wolff A; Stanley WC
J Card Fail; 2002 Dec; 8(6):416-22. PubMed ID: 12528095
[TBL] [Abstract][Full Text] [Related]
48. Usefulness of temporal changes in neurohormones as markers of ventricular remodeling and prognosis in patients with left ventricular systolic dysfunction and heart failure receiving either candesartan or enalapril or both.
Yan RT; White M; Yan AT; Yusuf S; Rouleau JL; Maggioni AP; Hall C; Latini R; Afzal R; Floras J; Masson S; McKelvie RS;
Am J Cardiol; 2005 Sep; 96(5):698-704. PubMed ID: 16125499
[TBL] [Abstract][Full Text] [Related]
49. Effects of exercise on left ventricular systolic and diastolic properties in patients with heart failure and a preserved ejection fraction versus heart failure and a reduced ejection fraction.
Zile MR; Kjellstrom B; Bennett T; Cho Y; Baicu CF; Aaron MF; Abraham WT; Bourge RC; Kueffer FJ
Circ Heart Fail; 2013 May; 6(3):508-16. PubMed ID: 23515277
[TBL] [Abstract][Full Text] [Related]
50. Chronic blocking of beta 3-adrenoceptor ameliorates cardiac function in rat model of heart failure.
Gan RT; Li WM; Xiu CH; Shen JX; Wang X; Wu S; Kong YH
Chin Med J (Engl); 2007 Dec; 120(24):2250-5. PubMed ID: 18167212
[TBL] [Abstract][Full Text] [Related]
51. Acute intravenous infusion of an adenosine regulating agent improves left ventricular function in dogs with advanced heart failure.
Wang M; Gupta RC; Rastogi S; Kohli S; Zhang K; Lanfear DE; Sabbah HN
Cardiovasc Drugs Ther; 2013 Dec; 27(6):489-98. PubMed ID: 23907235
[TBL] [Abstract][Full Text] [Related]
52. Role of heart rate reduction in the prevention of experimental heart failure: comparison between If-channel blockade and β-receptor blockade.
Becher PM; Lindner D; Miteva K; Savvatis K; Zietsch C; Schmack B; Van Linthout S; Westermann D; Schultheiss HP; Tschöpe C
Hypertension; 2012 May; 59(5):949-57. PubMed ID: 22493071
[TBL] [Abstract][Full Text] [Related]
53. Myocardial transfection with naked DNA plasmid encoding hepatocyte growth factor prevents the progression of heart failure in dogs.
Rastogi S; Guerrero M; Wang M; Ilsar I; Sabbah MS; Gupta RC; Sabbah HN
Am J Physiol Heart Circ Physiol; 2011 Apr; 300(4):H1501-9. PubMed ID: 21217070
[TBL] [Abstract][Full Text] [Related]
54. Soluble epoxide hydrolase inhibition improves myocardial perfusion and function in experimental heart failure.
Merabet N; Bellien J; Glevarec E; Nicol L; Lucas D; Remy-Jouet I; Bounoure F; Dreano Y; Wecker D; Thuillez C; Mulder P
J Mol Cell Cardiol; 2012 Mar; 52(3):660-6. PubMed ID: 22155238
[TBL] [Abstract][Full Text] [Related]
55. Prolonged effects of B-type natriuretic peptide infusion on cardiac remodeling after sustained myocardial injury.
George I; Morrow B; Xu K; Yi GH; Holmes J; Wu EX; Li Z; Protter AA; Oz MC; Wang J
Am J Physiol Heart Circ Physiol; 2009 Aug; 297(2):H708-17. PubMed ID: 19525373
[TBL] [Abstract][Full Text] [Related]
56. Proteasome inhibition decreases cardiac remodeling after initiation of pressure overload.
Hedhli N; Lizano P; Hong C; Fritzky LF; Dhar SK; Liu H; Tian Y; Gao S; Madura K; Vatner SF; Depre C
Am J Physiol Heart Circ Physiol; 2008 Oct; 295(4):H1385-93. PubMed ID: 18676687
[TBL] [Abstract][Full Text] [Related]
57. Chronic electrical stimulation of the carotid sinus baroreflex improves left ventricular function and promotes reversal of ventricular remodeling in dogs with advanced heart failure.
Sabbah HN; Gupta RC; Imai M; Irwin ED; Rastogi S; Rossing MA; Kieval RS
Circ Heart Fail; 2011 Jan; 4(1):65-70. PubMed ID: 21097604
[TBL] [Abstract][Full Text] [Related]
58. Exhaustion of Frank-Starling mechanism in conscious dogs with heart failure.
Komamura K; Shannon RP; Ihara T; Shen YT; Mirsky I; Bishop SP; Vatner SF
Am J Physiol; 1993 Oct; 265(4 Pt 2):H1119-31. PubMed ID: 8238398
[TBL] [Abstract][Full Text] [Related]
59. Echocardiography, a non-invasive method for the investigation of heart morphology and function in laboratory dogs: 2. Effects of minoxidil and quinidine on the left ventricle function.
Hanton G; Lodola A
Lab Anim; 1998 Apr; 32(2):183-90. PubMed ID: 9587901
[TBL] [Abstract][Full Text] [Related]
60. Long-term administration of ranolazine attenuates diastolic dysfunction and adverse myocardial remodeling in a model of heart failure with preserved ejection fraction.
De Angelis A; Cappetta D; Piegari E; Rinaldi B; Ciuffreda LP; Esposito G; Ferraiolo FA; Rivellino A; Russo R; Donniacuo M; Rossi F; Urbanek K; Berrino L
Int J Cardiol; 2016 Aug; 217():69-79. PubMed ID: 27179211
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
